Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001)

BACKGROUND: Penis cancer is rare and clinical trial evidence on which to base treatment decisions is limited. Case reports suggest that the combination of docetaxel, cisplatin and 5-flurouracil (TPF) is highly active in this disease. METHODS: Twenty-nine patients with locally advanced or metastatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicholson, S, Hall, E, Harland, S J, Chester, J D, Pickering, L, Barber, J, Elliott, T, Thomson, A, Burnett, S, Cruickshank, C, Carrington, B, Waters, R, Bahl, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833214/
https://www.ncbi.nlm.nih.gov/pubmed/24169355
http://dx.doi.org/10.1038/bjc.2013.620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833214/
https://www.ncbi.nlm.nih.gov/pubmed/24169355
http://dx.doi.org/10.1038/bjc.2013.620

Ejemplares similares